Published by Reuters By Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Antibody protection from mild COVID-19 may not last Nearly everyone who had a mild case … Continue reading Antibody protection after mild COVID-19 may not last; an estimated 100 million people have had long COVID